Search research articles
Contact Us
Filters
Showing results (41-50 of 77) with videos related to
Page
of 8
Sort By:
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
August 13, 2004
Radiotherapy wait times for patients with a diagnosis of invasive cancer, 1992-2000
Grace M Johnston, Vicki L MacGarvie, David Elliott, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 4, 2022
Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung Cancer
Alex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 22, 2022
Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant Durvalumab
Alex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
BMC Biochemistry
|
July 11, 2014
Application of Gaussia luciferase in bicistronic and non-conventional secretion reporter constructs
Christin Luft, Jamie Freeman, David Elliott, et al.
Plos One
|
November 8, 2012
Defining the cause of death in hospitalised patients with acute kidney injury
Nicholas M Selby, Nitin V Kolhe, Christopher W McIntyre, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2026
Heterogeneous survival impact of immune-related adverse events in US veterans
Sadiq Rehmani, Luke Michael Higgins, Daria Brinzevich, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 13, 2021
Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer
Alex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
Journal of Leukocyte Biology
|
January 30, 2019
Loss of RHBDF2 results in an early-onset spontaneous murine colitis
Ramasatyaveni Geesala, Willow Schanz, Mikayla Biggs, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2022
De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer
Alex K Bryant, Kamya Sankar, Lili Zhao, et al.
Microorganisms
|
November 27, 2024
Cast from the Past? Microbial Diversity of a Neolithic Stone Circle
Mercedes Martín-Cereceda, Amaya de Cos-Gandoy, Richard A J Williams, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 77) with videos related to
Sort By:
Page
of 8
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
August 13, 2004
Radiotherapy wait times for patients with a diagnosis of invasive cancer, 1992-2000
Grace M Johnston, Vicki L MacGarvie, David Elliott, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 4, 2022
Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung Cancer
Alex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 22, 2022
Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant Durvalumab
Alex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
BMC Biochemistry
|
July 11, 2014
Application of Gaussia luciferase in bicistronic and non-conventional secretion reporter constructs
Christin Luft, Jamie Freeman, David Elliott, et al.
Plos One
|
November 8, 2012
Defining the cause of death in hospitalised patients with acute kidney injury
Nicholas M Selby, Nitin V Kolhe, Christopher W McIntyre, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2026
Heterogeneous survival impact of immune-related adverse events in US veterans
Sadiq Rehmani, Luke Michael Higgins, Daria Brinzevich, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 13, 2021
Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer
Alex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
Journal of Leukocyte Biology
|
January 30, 2019
Loss of RHBDF2 results in an early-onset spontaneous murine colitis
Ramasatyaveni Geesala, Willow Schanz, Mikayla Biggs, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2022
De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer
Alex K Bryant, Kamya Sankar, Lili Zhao, et al.
Microorganisms
|
November 27, 2024
Cast from the Past? Microbial Diversity of a Neolithic Stone Circle
Mercedes Martín-Cereceda, Amaya de Cos-Gandoy, Richard A J Williams, et al.
Page
of 8